Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug;7(8):e2111.
doi: 10.1002/cnr2.2111.

Multimodal treatment according to the NPC-GPOH trials in adult patients with nasopharyngeal cancer-Analysis based on a single-center experience

Martin Leu  1 , Hanibal Bohnenberger  2 , Manuel Guhlich  1 , Markus Anton Schirmer  1 , Yiannis Pilavakis  3 , Hendrik Andreas Wolff  4   5   6 , Stefan Rieken  1 , Leif Hendrik Dröge  1
Affiliations

Multimodal treatment according to the NPC-GPOH trials in adult patients with nasopharyngeal cancer-Analysis based on a single-center experience

Martin Leu et al. Cancer Rep (Hoboken). 2024 Aug.

Abstract

Background and aim: The German NPC-GPOH trials introduced treatment including neoadjuvant chemotherapy, radiochemotherapy (RCT) and antiviral treatment in patients aged 25 years or younger with nasopharyngeal cancer (NPC). We conducted a retrospective study on outcomes of patients at the age of ≥26 years treated accordingly at our institution.

Methods: Consecutive patients who received primary RCT for NPC were included. The Kaplan-Meier method was used to calculate survival probabilities, and the Cox regression analysis was used to test for an influence of the variables on outcomes. Acute and late toxicity were evaluated via CTCAE criteria and LENT/SOMA criteria, respectively.

Results: In total, 30 patients were included. Diagnosis was made from 09/1994 to 11/2016. The median 5 year overall survival (OS), disease-free survival (DFS), cancer-specific survival (CSS) and locoregional recurrence-free survival (LRC) were 75%, 56%, 83%, and 85%, respectively. We found a negative impact on outcomes (p < .05) in case of older age (OS), history of smoking (OS), and T4 stage/ UICC stage IV (DFS). WHO histologic type significantly influenced outcomes, with best outcomes for type III and worst outcomes for type I. The rates of acute and late toxicities were acceptable.

Conclusion: We found excellent outcomes and good feasibility of the NPC-GPOH trials regimen in adult patients. Additionally, we identified patients with outcomes which need to be improved (smokers, histologic type I tumors) and with particularly excellent outcomes (histologic type III tumors). This stimulates further studies on treatment intensification or de-escalation aiming at reduced side effects with optimal tumor control in NPC.

Keywords: NPC‐GPOH trials; WHO histological type; antiviral treatment; interferon‐β; nasopharyngeal cancer; radiochemotherapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

FIGURE 1
FIGURE 1
Overall survival for the whole patient cohort.
See this image and copyright information in PMC

References

    1. Chua MLK, Wee JTS, Hui EP, Chan ATC. Nasopharyngeal carcinoma. Lancet. 2016;387:1012‐1024. - PubMed
    1. Downing NL, Wolden S, Wong P, Petrik DW, Hara W, Le QT. Comparison of treatment results between adult and juvenile nasopharyngeal carcinoma. International Journal of Radiation Oncology, Biology, Physics. 2009;75:1064‐1070. - PubMed
    1. Kontny U, Franzen S, Behrends U, et al. Diagnosis and treatment of nasopharyngeal carcinoma in children and adolescents‐recommendations of the GPOH‐NPC Study Group. Klinische Pädiatrie. 2016;228:105‐112. - PubMed
    1. Barnes L, Eveson JW, Reichart P, Sidransky D. pathology and genetics of head and neck tumours, WHO classification of tumours. 3rd ed. IARC; 2005:84.
    1. Peterson BR, Nelson BL. Nonkeratinizing undifferentiated nasopharyngeal carcinoma. Head and Neck Pathology. 2013;7:73‐75. - PMC - PubMed

MeSH terms

Substances

LinkOut - more resources